Indication

Anemia in chronic kidney disease

Anemia in chronic kidney disease is a common hematologic complication characterized by a subnormal circulating red blood cell mass and hemoglobin level secondary to progressive renal impairment. Read more about Anemia in chronic kidney disease

26 drugs 18 manufacturers

Advertisement

Drugs that treat it

Common Anemia in chronic kidney disease therapies.

Showing 1–9 of 26 drugs

Filter & compare in the drug finder →Opens the drug finder with Anemia in chronic kidney disease preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Anemia in chronic kidney disease.

Anemia in chronic kidney disease is a common hematologic complication characterized by a subnormal circulating red blood cell mass and hemoglobin level secondary to progressive renal impairment.

It primarily affects pediatric and adult patients with moderate-to-severe renal dysfunction, increasing in frequency and severity as renal filtration declines.

Pathophysiologically, the condition is typically a normocytic, normochromic, hypoproliferative anemia driven fundamentally by deficient erythropoietin synthesis from damaged renal peritubular interstitial cells.

It is compounded by systemic inflammation with elevated hepcidin concentrations that produce functional iron restriction, shortened erythrocyte survival, and chronic uremic platelet or blood loss.

Personalize your experience

Follow Anemia in chronic kidney disease and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it